Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New beta3-adrenoceptor agonists discovered at Lilly

April 1, 2003

New glucokinase activators in early development at AstraZeneca

April 1, 2003

Aventis presents new MCH receptor modulators with anorectic activity

April 1, 2003

Novel therapeutic strategies for diabetes

April 1, 2003

Abbott and Karo Bio identify novel new compound for type 2 diabetes

March 31, 2003

Lion Bioscience presents novel FXR modulators for lipid disorders and cancer

March 31, 2003

KUR-1246 more effective than other beta2-agonists in rats with preterm labor

March 28, 2003

ADVOCATE data reveal Advicor to be highly effective for lipid disorders

March 28, 2003

FDA extends review period for Tostrex NDA

March 28, 2003

New ERbeta agonists and their use in hot flushes and depression

March 28, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...